Press
MEDTECH ACQUISITION, PARTNERING & INVESTMENT OPPORTUNITIES SHOWCASED ONLINE AUGUST 11, 2010, HOSTED BY LIFE SCIENCE INTELLIGENCE
HUNTINGTON BEACH, Calif.-August 5, 2010--(BUSINESS WIRE)— Life Science Intelligence (LSI) announced today that 27 emerging medical technology companies will be showcased at their upcoming Emerging Medical Technologies Spotlight – an online meeting being held on August 11, 2010 at 11 a.m. Eastern, sponsored by MedC.Partners, Rutan & Tucker, and Medical Capital Advisors.
Furthermore, medical technology investment banking veteran Christopher J.P. Velis of Medical Capital Advisors will kick off the meeting with an industry presentation titled “The Medtech Climate in the New Economy: 7 Things You Need to Know About Raising Capital, Valuations, and Exit Strategies”.
Mr. Velis’ discussion will be followed by detailed business presentations from the CEOs of 27 privately-held emerging medical technology companies selected by event host Life Science Intelligence. Each of the presenting companies is raising capital and/or seeking strategic partners/acquisition.
Attendees to the meeting get online access to:
- Mr. Velis' Industry Presentation
- CEO Presentations on these 27 Emerging Companies - Complete with 10-15 Minute Audio
- The Notebook of 27 Executive Summaries
- In-Depth Content, Including: Development Stage, Competitive Landscape and Positioning, Technological Advantage, Target Markets, Sales Forecasts, Strategic Partnering Opportunities, Financial & Fund Raising Status, Management Team, IP Position, Exit Strategy, Contact Details & More
- The “Live” Event on August 11, 2010 and On-Demand “Replays” for 12 Months Thereafter
- Optional Networking
Companies presenting their opportunities on August 11th include:
- Aespira
- Appiades Meditech
- Biomedica
- CritiSense
- CytoSorbents
- Genomic Expression
- Headway
- ImmunoChemistry Technologies
- Intellewave
- Intrapartum
- IVDiagnostics
- Magellan Spine Technologies
- MenRx Surgical
- Micronics
- NanoCor Therapeutics
- NuOrtho Surgical
- Omnivus
- OrthoAccel Technologies
- Pluristem Therapeutics
- Pro-IV Medical
- Silere Medical Technology
- SMT R&D
- SpineSmith
- Stellarray
- TechniScan Medical Systems
- TonoGuard
- VasoNova
LSI’s Emerging Medical Technologies Spotlight is a travel-free online event, which serves as a convenient forum for medical technology innovators, investors, and dealmakers to connect and collaborate from their desktops. Registered attendees and select LSI members – which include the top medtech dealmaking companies and venture capital firms – will have an opportunity to quickly and efficiently preview companies and then selectively network using LSI’s proprietary and confidential online platform.
To register for this private online event or for additional details, visit www.EMTspotlight.com.
About Medical Capital Advisors, LLC
Medical Capital Advisors, LLC is among Wall Street's leading, specialized investment banking advisors to the Medical Technology industry. The firm has successfully represented the financial interests of sophisticated institutional investors and Fortune 500 companies. Medical Capital Advisors' current client base includes leading medical technology firms in the largest sectors of medicine, including: orthopedic, cardiovascular, and biologic sciences. Medical Capital Advisors provides strategic advice concerning mergers and acquisitions, strategic partnerships, and capital investments to its clients.
About Life Science Intelligence (LSI)®
LSI delivers high-quality market data and competitive intelligence to medical technology executives, entrepreneurs, and investors. LSI produces the comprehensive Emerging Medical Technologies® database, quarterly Emerging Medical Technologies® online meetings, traditional market reports, deeply segmented and frequently updated Market Agents™, and global custom market research.
Contact:
Life Science Intelligence
Scott Pantel, 1-714-847-3540
scott@LifeScienceIntelligence.com
www.LifeScienceIntelligence.com
